🇺🇸 FDA
Patent

US 8540997

Complement receptor 1 and 2 fusion proteins

granted A61KA61K38/00A61P

Quick answer

US patent 8540997 (Complement receptor 1 and 2 fusion proteins) held by The Regents of the University of Colorado, a Body Corporate expires Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Sep 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K38/00, A61P, A61P1/00, A61P1/04